London AI drug discovery startup Boltz raises $110M Series A
This story is from 2026-11-19. It is preserved in the archive; the latest stories are on the live feed.
London-based AI drug discovery startup Boltz has raised a $110 million Series A funding round, less than a year after emerging from stealth. The company develops AI models to speed up drug discovery research.
Read the full story at Tech.eu ↗
Timeline · 1 report
- 2026-11-19 10:04 · Tech.eu
London-based Boltz raises $110M Series A